BCAX analyst estimates

Bicara Therapeutics (BCAX) analyst ratings, the average price target and its range, and every firm's latest call.

• 8 firms rate BCAX: 5 buy, 2 hold, 1 sell.
• The average price target is $31.57 from None analysts, from $20.00 to $42.00.

Updated 2026-11-10 04:45 UTC